Oakmont Advisory Group, LLC

Position in EXEL — Exelixis, Inc.

CIK 2115370 ALBUQUERQUE, NM

Position in EXEL

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$412,591

+$76,720 QoQ

Shares Held

7,583

-3.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.99%

of 13F equity value

Holder Rank

#465

of 751 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Oakmont Advisory Group, LLC holds $853,774 across 5 Biotechnology names. EXEL ranks #1 (48.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	7,583	$412,591
2	HALO	Halozyme Therapeutics, Inc.	4,953	$387,671
3	INCY	Incyte Corp	461	$52,258
4	REGN	Regeneron Pharmaceuticals, Inc.	2	$1,247
5	VKTX	Viking Therapeutics, Inc.	0	$7

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$412,591	7,583	-3.2%	Shares	Sole	2026-08-03
2026-03-31	$335,871	7,831	+6.9%	Shares	Sole	2026-05-12
2025-12-31	$321,054	7,325	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.